Correlation Between Cingulate and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cingulate and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Cingulate and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate and Lipella Pharmaceuticals.
Diversification Opportunities for Cingulate and Lipella Pharmaceuticals
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cingulate and Lipella is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Cingulate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Cingulate i.e., Cingulate and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cingulate and Lipella Pharmaceuticals
Given the investment horizon of 90 days Cingulate is expected to generate 0.86 times more return on investment than Lipella Pharmaceuticals. However, Cingulate is 1.17 times less risky than Lipella Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about -0.01 per unit of risk. If you would invest 439.00 in Cingulate on August 30, 2024 and sell it today you would lose (19.00) from holding Cingulate or give up 4.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cingulate vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| Cingulate |
| Lipella Pharmaceuticals |
Cingulate and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate and Lipella Pharmaceuticals
The main advantage of trading using opposite Cingulate and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| Cingulate vs. SAB Biotherapeutics | Cingulate vs. Senti Biosciences | Cingulate vs. Aerovate Therapeutics | Cingulate vs. Adagene |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |